Retatrutide Research
Retatrutide is a synthetic multi-receptor agonist peptide researched in endocrine chemistry, metabolic signaling, and energy homeostasis models. Designed as a single peptide chain containing 39 amino acids, Retatrutide simultaneously engages three primary metabolic receptor systems: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon (GCG) receptor.
Alluvi HealthCare UK supplies high-purity, laboratory-grade Retatrutide formulated specifically for in vitro testing, assay development, and biochemical research protocols across the United Kingdom and Europe.
Retatrutide Technical & Physical Specifications
In controlled laboratory environments, precise structural composition is essential for achieving consistent binding kinetics and reproducible assay data.
| Parameter | Specification |
| Chemical Name | Retatrutide |
| Molecular Class | Synthetic Peptides / Multi-Receptor Agonist |
| Sequence Length | 39 Amino Acids |
| Physical Form | Lyophilized (Freeze-Dried) Solid Cake / Powder |
| Target Purity Grade | <=98.0% (HPLC Peak Area Integration) |
| Identity Verification | Mass Spectrometry ($M_{obs}$ matches Theoretical Mass) |
| Recommended Storage | Store at -20°C; protect from light and ambient humidity |
| Designated Use | Laboratory Research & In Vitro Assays Only |
Research Applications of Retatrutide
In biochemical and cell culture studies, Retatrutide serves as a key reference compound for evaluating multi-pathway signaling cascades:
- Triple-Agonist Receptor Kinetics: Used in binding assays to analyze how simultaneous engagement of GIP, GLP-1, and GCG receptors alters intracellular cyclic AMP (cAMP) production.
- Metabolic Pathway Mapping: Utilized in tissue models to study downstream enzymatic cascades governing cellular lipid metabolism and glucose uptake.
- Comparative Receptor Affinity Studies: Provides a benchmark compound when comparing single-agonist or dual-agonist ligands against multi-receptor peptide structures.
Analytical Verification & Batch Quality Control
Every batch of Retatrutide supplied by Alluvi HealthCare UK undergoes strict analytical testing to verify physical form, molecular identity, and quantitative purity.
- Identity Confirmation: Verified using Electrospray Ionization Mass Spectrometry (ESI-MS) to ensure the observed molecular weight corresponds to the 39-amino-acid target sequence.
- Purity Measurement: Assessed via High-Performance Liquid Chromatography (HPLC). Batch release criteria require a primary peak integration area of <=98.0%.
- Batch Traceability: Each vial features a unique lot code matching its corresponding Certificate of Analysis.
To review sitewide testing frameworks, visit our Quality & Testing Page. To inspect or request lot documentation, access our Certificate of Analysis Portal.
Handling and Laboratory Storage Protocol
To prevent molecular degradation and preserve structural integrity, laboratory personnel should adhere to the following storage parameters:
- Dry Lyophilized Storage: Maintain unopened vials at -20°C for long-term stability. Avoid repeated temperature cycling.
- Desiccation: Allow cold vials to equilibrate to room temperature inside a desiccator before opening to prevent ambient moisture condensation on the lyophilized cake.
- Reconstitution Handling: Once reconstituted for experimental protocols, handle solutions under aseptic laboratory conditions and store aliquots at low temperatures as dictated by trial timelines.
For expanded handling resources, consult the Alluvi Research Library.
Ordering Retatrutide from Alluvi HealthCare UK
Alluvi HealthCare UK supplies research-grade Retatrutide with transparent batch documentation, secure cold-chain packaging, and fast fulfillment across the UK and Europe.
- Available Unit Sizes: Select required vial quantities using the product options menu below.
- Document Inclusion: Batch-specific CoA records are available for every shipped lot.
- Catalog Context: Explore related materials in our broader Research Peptides Category or main Research Compounds Catalog.
- Related Product: Tirzepatide.
Retatrutide FAQs
What is Retatrutide?
Retatrutide is a 39-amino-acid synthetic research peptide designed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways in biochemical research.
What purity level is expected for Retatrutide research materials?
Alluvi HealthCare UK specifies a minimum target purity of <= 98.0% for Retatrutide, verified by HPLC peak integration.
What documentation accompanies Retatrutide orders?
Each Retatrutide batch is supported by a lot-specific Certificate of Analysis detailing observed mass spectrometry figures and HPLC purity percentages.
How should Retatrutide be stored upon arrival?
Unopened lyophilized vials should be stored at -20°C in a dry environment, protected from direct light exposure.
Is Retatrutide intended for human consumption?
No. Retatrutide supplied by Alluvi HealthCare UK is strictly intended for laboratory research, in vitro experimentation, and analytical studies. It is not for human, clinical, or therapeutic use.